Using Mesenchymal Stem Cells to Treat Alzheimer’s Disease  

album-art
00:00
Sorry, no results.
Please try another keyword

Alzheimer’s disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and changes in behavior and personality. It is the most common cause of dementia in the elderly. Currently, there are limited treatment options available that can only temporarily alleviate symptoms but do not stop or reverse the disease progression. However, new research shows promise for mesenchymal stem cell therapy derived from umbilical cord tissue as a potential disease-modifying treatment.

Overview of Alzheimer’s Disease

The hallmark pathologies of Alzheimer’s disease are the accumulation of amyloid beta plaques and neurofibrillary tangles containing tau protein in the brain. This leads to neuronal dysfunction, neuroinflammation, loss of synapses and neurons, and brain atrophy.

The causes of Alzheimer’s disease are not fully understood but include a combination of genetic, lifestyle, and environmental factors. The biggest risk factor is increasing age. Alzheimer’s usually begins slowly with mild cognitive impairment and worsens over time as more neurons die.

Currently, there is no cure for Alzheimer’s disease, and available treatments only provide modest symptomatic relief but do not slow disease progression. As the global population ages, the prevalence of Alzheimer’s is projected to increase dramatically in the coming decades. This highlights the urgent need for developing new disease-modifying therapies.

Mesenchymal Stem Cells as a Promising Therapy

Mesenchymal stem cells (MSCs) are adult stem cells found in various tissues in the body, including bone marrow, adipose tissue, and umbilical cord tissue. They have unique properties that make them a promising potential therapy for Alzheimer’s disease, including:

  • Immunomodulation: MSCs can regulate inflammation and immune responses in the brain which drive Alzheimer’s disease progression. They secrete anti-inflammatory cytokines and interact with immune cells to dampen inflammation.
  • Tissue repair and regeneration: MSCs secrete growth factors and extracellular vesicles that stimulate new neuron formation, synaptogenesis, angiogenesis, and overall brain repair processes.
  • Pluripotency: MSCs can differentiate into various cell types, including neuron-like cells, which may help replace lost neurons.
  • Migration to injury sites: When injected intravenously, MSCs can migrate to areas of neuroinflammation and damage in the brain.
  • Amyloid beta clearance: MSCs can take up and degrade amyloid beta, clearing toxic plaques from the brain.

Numerous pre-clinical studies have shown that MSC treatment can significantly improve cognitive function, reduce Alzheimer’s pathology, and stimulate regeneration in the brain. MSCs sourced from umbilical cord tissue are advantageous as they are more primitive, have higher proliferation rates, and have longer telomeres compared to MSCs from adult tissues.

Clinical Trials of MSC Therapy for Alzheimer’s

Encouraged by pre-clinical findings, human clinical trials are now underway to evaluate the safety and efficacy of MSC therapy for Alzheimer’s disease.Some examples of ongoing or recently completed trials include:

  • NCT03117738: Phase 1/2 trial administering intravenous umbilical cord-derived MSCs in patients with mild to moderate Alzheimer’s.
  • NCT04040348: Phase 1 trial of intravenous bone marrow-derived MSCs in Alzheimer’s patients.
  • NCT02600130: Phase 2 trial of intravenous MSCs in patients with mild to moderate Alzheimer’s.
  • NCT02672306: Phase 1/2 safety and efficacy trial of intravenous umbilical cord MSCs in Alzheimer’s patients.

The Future of MSC Therapy for Alzheimer’s Treatment

In conclusion, mesenchymal stem cells derived from umbilical cord tissue present a promising new approach to treating Alzheimer’s disease and modifying disease progression. These studies and early clinical trials support their safety and potential efficacy. MSC therapy could transform the treatment paradigm for Alzheimer’s from just symptom management to targeting root causes like inflammation and cell loss. This provides new hope to the millions suffering from this debilitating neurodegenerative disease worldwide.

At Stem Cell Medical Center, we offer mesenchymal stem cell therapy for many conditions using allogeneic umbilical cord-derived MSCs. To determine if you may qualify for our treatments, please contact us today to speak with one of our patient care coordinators. We are dedicated to advancing the science of regenerative medicine to help patients with incurable diseases through stem cell research and responsible clinical applications.